Microparticles from ischemic muscle promotes postnatal vasculogenesis

Circulation. 2009 Jun 2;119(21):2808-17. doi: 10.1161/CIRCULATIONAHA.108.816710. Epub 2009 May 18.

Abstract

Background: We hypothesized that microparticles (MPs) released after ischemia are endogenous signals leading to postischemic vasculogenesis.

Methods and results: MPs from mice ischemic hind-limb muscle were detected by electron microscopy 48 hours after unilateral femoral artery ligation as vesicles of 0.1- to 1-microm diameter. After isolation by sequential centrifugation, flow cytometry analyses showed that the annexin V(+) MP concentration was 3.5-fold higher in ischemic calves than control muscles (1392+/-406 versus 394+/-180 annexin V(+) MPs per 1 mg; P<0.001) and came mainly from endothelial cells (71% of MPs are CD(144+)). MPs isolated from ischemic muscles induced more potent in vitro bone marrow-mononuclear cell (BM-MNC) differentiation into cells with endothelial phenotype than those isolated from control muscles. MPs isolated from atherosclerotic plaques were ineffective, whereas those isolated from apoptotic or interleukin-1beta-activated endothelial cells also promoted BM-MNC differentiation. Interestingly, MPs from ischemic muscles produced more reactive oxygen species and expressed significantly higher levels of NADPH oxidase p47 (6-fold; P<0.05) and p67 subunits (16-fold; P<0.001) than controls, whereas gp91 subunit expression was unchanged. BM-MNC differentiation was reduced by 2-fold with MPs isolated from gp91-deficient animals compared with wild-type mice (P<0.05). MP effects on postischemic revascularization were then examined in an ischemic hind-limb model. MPs isolated from ischemic muscles were injected into ischemic legs in parallel with venous injection of BM-MNCs. MPs increased the proangiogenic effect of BM-MNC transplantation, and this effect was blunted by gp91 deficiency. In parallel, BM-MNC proangiogenic potential also was reduced in ABCA1 knockout mice with impaired vesiculation.

Conclusions: MPs produced during tissue ischemia stimulate progenitor cell differentiation and subsequently promote postnatal neovascularization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter 1
  • ATP-Binding Cassette Transporters / genetics
  • ATP-Binding Cassette Transporters / physiology
  • Animals
  • Annexin A5 / pharmacology
  • Cell Differentiation
  • Cell Hypoxia
  • Cell-Derived Microparticles / physiology*
  • Cell-Derived Microparticles / transplantation
  • Endothelial Cells / pathology
  • Endothelium, Vascular / pathology
  • Enzyme Induction
  • Femoral Artery
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Ischemia / blood*
  • Ischemia / physiopathology
  • Ischemia / surgery
  • Ligation
  • Membrane Glycoproteins / biosynthesis
  • Membrane Glycoproteins / genetics
  • Mice
  • Mice, Knockout
  • Muscle, Skeletal / blood supply*
  • NADPH Oxidase 2
  • NADPH Oxidases / biosynthesis
  • NADPH Oxidases / genetics
  • Neovascularization, Physiologic / physiology*
  • Reactive Oxygen Species

Substances

  • ABCA1 protein, human
  • ATP Binding Cassette Transporter 1
  • ATP-Binding Cassette Transporters
  • Annexin A5
  • Membrane Glycoproteins
  • Reactive Oxygen Species
  • Cybb protein, mouse
  • NADPH Oxidase 2
  • NADPH Oxidases
  • neutrophil cytosolic factor 1